The insider, Director William Doyle, acquired 15,000 shares of Elanco Animal Health Inc on March 8, 2024. The company operates globally, providing a range of products that cater to the needs of companion and food animals. Insider transactions are closely monitored as they can signal a belief in the company's future prospects or that the stock is undervalued. This latest transaction is part of a trend observed over the past year.